A cyclic analogue selective for the NKB specific binding site on rat brain synaptosomes

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Neurokinin B (NKB) is a key peptide in the tachykinin family, involved in various physiological processes.
• Understanding the structure-activity relationships of NKB analogues is crucial for developing targeted therapeutics.
• Previous studies have explored modifications of NKB to investigate its receptor interactions.

Purpose of the Study:

• To evaluate the biological activity and receptor binding selectivity of the cyclic NKB analogue, [Cys2,Cys5]NKB.
• To compare the potency of [Cys2,Cys5]NKB with native NKB and substance P (SP) in a functional assay.
• To determine the binding characteristics of [Cys2,Cys5]NKB at specific tachykinin binding sites.

Main Methods:

• Guinea-pig ileum bioassay to assess contractile activity.
• Radioligand binding assays using rat cortical synaptosomes.
• Determination of IC50 values for [3H]NKB and 125I-BHSP binding sites.

Main Results:

• The cyclic analogue [Cys2,Cys5]NKB exhibited comparable activity to SP and NKB in the guinea-pig ileum bioassay.
• [Cys2,Cys5]NKB was identified as a selective substrate for the [3H]NKB specific binding site on rat cortical synaptosomes.
• Binding potencies (IC50) for [3H]NKB and 125I-BHSP sites were 5.2 nM and 3.4 microM, respectively, closely mirroring those of NKB.

Conclusions:

• The cyclic modification of NKB preserves its biological activity and enhances its selectivity for the NKB binding site.
• [Cys2,Cys5]NKB represents a valuable tool for studying NKB receptor pharmacology.
• This analogue holds potential for further investigation in neurological and physiological contexts related to the tachykinin system.